Ethena price jumps 5% as USDe expansion fuels fresh breakout hopes
Ethena price has risen nearly 5% in the past 24 hours as multichain expansion and steady USDe demand have boosted investor interest. According
Economy
Economy
EasyJet reports sharp Q3 profit drop despite stronger summer demand
EasyJet reported a 70% year-on-year decline in fiscal third-quarter profit on Thursday. The airline said disruption from the Iran war had increased costs
Economy
SMCI stock surges 18%: why is Goldman Sachs still refusing to turn bullish?
Super Micro Computer stock (NASDAQ: SMCI) surged 18% after the AI-server maker delivered a profitability surprise, but Goldman Sachs remains firmly unconvinced that
Economy
JD Wetherspoon shares sink after another profit warning: why are UK pubs struggling?
JD Wetherspoon shares fell about 9% on Wednesday after the pub chain warned that full-year profits are likely to come in below market
Economy
HYPE falls below $60: are ETF outflows signalling more pain ahead?
Hyperliquid (HYPE) remained under pressure on Wednesday, trading below the $60 mark as buyers struggled to push the token above its 50-day Exponential
Economy
Cardano hits a wall near $0.178 as leveraged demand starts to fade
Cardano (ADA) is down by 1.5% on Wednesday after failing to overcome resistance at the 50-day Exponential Moving Average (EMA) near $0.1770. The
Economy
Airbus stock jumps on share buyback, 2029 profit target: why analysts see upside
Airbus shares surged more than 7% on Wednesday after the European aerospace giant unveiled a €5 billion ($5.7 billion) share buyback programme and
Economy
XRP stalls below key EMAs: is this recovery weaker than it looks?
Ripple’s XRP has been consolidating over the past few hours and is trading around $1.13. The performance comes as improving risk appetite sparked
Economy
Intel stock earnings could expose the fault line beneath its AI comeback
Intel stock (NASDAQ: INTC) heads into Thursday’s earnings with expectations running ahead of a turnaround story. Shares remain up more than 160% this
Economy
Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims
Novo Nordisk has filed a lawsuit against Eli Lilly (LLY) in a US federal court, accusing its rival of running false and misleading